{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:59Z","timestamp":1786119359607,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/mbc.0b013e32832da1ad","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T14:49:57Z","timestamp":1250174997000},"page":"475-483","source":"Crossref","is-referenced-by-count":20,"title":["Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease"],"prefix":"10.1097","volume":"20","author":[{"given":"Emmanuel J","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Baccala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Koutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210203","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R2-17-20210203","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2006-947859","article-title":"Laboratory identification of von Willebrand Disease: technical and scientific perspectives","volume":"32","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R3-17-20210203","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding (VWF:CB) assay: 21 years of age and beyond adolescence, but not yet a mature adult","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"R4-17-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"R5-17-20210203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.2004.00886.x","article-title":"Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Pasi","year":"2004","journal-title":"Haemophilia"},{"key":"R6-17-20210203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"R7-17-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2004.00894.x","article-title":"The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Laffan","year":"2004","journal-title":"Haemophilia"},{"key":"R8-17-20210203","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0029-1145254","article-title":"Clinical utility of the PFA-100","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"R9-17-20210203","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1055\/s-2006-949662","article-title":"Laboratory monitoring of therapy in von Willebrand Disease: efficacy of the PFA-100 and VWF:CB as coupled strategies","volume":"6","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R10-17-20210203","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2002-27814","article-title":"Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications","volume":"28","author":"Michiels","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"R11-17-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1076029606291401","article-title":"Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD","volume":"12","author":"Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"R12-17-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1076029606296399","article-title":"Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3","volume":"13","author":"Michiels","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"R13-17-20210203","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1160\/TH07-08-0527","article-title":"PFA-100 monitoring of von Willebrand factor (VWF) responses to DDAVP and FVIII\/VWF concentrate substitution in von Willebrand disease type 1 and 2","volume":"100","author":"van Vliet","year":"2008","journal-title":"Thromb Haemost"},{"key":"R14-17-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R15-17-20210203","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.thromres.2008.10.008","article-title":"Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?","volume":"123","author":"Favaloro","year":"2009","journal-title":"Thromb Res"},{"key":"R16-17-20210203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-2007-1000367","article-title":"Time to think outside the box? Proposals for a new approach to future pharmacokinetic studies of von Willebrand factor concentrates in people with von Willebrand disease","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"R17-17-20210203","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3324\/haematol.11313","article-title":"Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry","volume":"92","author":"Giannini","year":"2007","journal-title":"Haematologica"},{"key":"R18-17-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2516.2008.01672.x","article-title":"Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders","volume":"14","author":"Hanebutt","year":"2008","journal-title":"Haemophilia"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200909000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:04Z","timestamp":1786039684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200909000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832da1ad","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}